Dr Jon Granbois, in Walla Walla, WA - Pharmacist

Dr Jon Granbois, is a Pharmacist based in Walla Walla, Washington. Dr Jon Granbois is licensed to practice in Washington (license number PH60470396) and his current practice location is 633 W Tietan St, Walla Walla, Washington. He can be reached at his office (for appointments etc.) via phone at (509) 529-1570.

NPI number for Dr Jon Granbois is 1043609431 and his current mailing address is 916 Martin Dr, Walla Walla, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043609431.

Contact Information

	Dr Jon Granbois,
	633 W Tietan St, Walla Walla, WA 99362-4329
	(509) 529-1570
	Not Available

Healthcare Provider's Profile

Full Name	Dr Jon Granbois
Gender	Male
Speciality	Pharmacist
Location	633 W Tietan St, Walla Walla, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1043609431
Provider Enumeration Date: 01/22/2015
Last Update Date: 01/22/2015

Medical Identifiers

Medical identifiers for Dr Jon Granbois such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043609431	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PH60470396 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jon Granbois is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jon Granbois, 916 Martin Dr, Walla Walla, WA 99362-1528 Ph: () -	Dr Jon Granbois, 633 W Tietan St, Walla Walla, WA 99362-4329 Ph: (509) 529-1570

News Archive

Reform necessary to overcome challenges to polio eradication efforts in Pakistan

In this Huffington Post opinion piece, Sania Nishtar, founder of Heartfile and the recently launched Sania Nishtar Health Fund, writes that "after 23 years of commencing the World Health Organization-led Global Polio Eradication Initiative, billions of dollars in investment, mobilization of 20 million health workers and a population wide intervention in 125 countries, vaccinating more than two billion children, there are only four countries in the world which continue to harbor the disease," and Pakistan is "a living threat to the global goal of eradicating a disease for the second time from the face of this planet."

Acceptance of initial regulatory filings for BMS-PCSK9Rx triggers $6M milestone payment to Isis Pharmaceuticals

Isis Pharmaceuticals, Inc. announced today that it has earned a $6 million milestone payment from Bristol-Myers Squibb Company related to the acceptance of initial regulatory filings to begin Phase 1 clinical studies for BMS-PCSK9Rx. BMS-PCSK9Rx is an antisense drug that arose out of the ongoing collaboration between Bristol-Myers Squibb and Isis to identify antisense drugs targeting PCSK9 to lower low-density lipoprotein (LDL) cholesterol.

New era of scientific innovation to drive novel ways of treating, preventing HIV

The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference taking place in Vienna, Austria said today. And, with millions of lives dependent on expanding access to antiretroviral treatment to all those clinically in need, researchers and clinicians are partnering in new ways to find the most effective and efficient methods to deliver treatment and strengthen health systems.

Special journal section explores geriatric assessment

The latest issue of The Journal of Gerontology: Medical Sciences (Vol. 63, No. 3) features a special section devoted to the phenomenon of multidimensional geriatric assessment - an interdisciplinary diagnostic process to determine the medical, psychological, and functional status of at-risk and frail elderly patients in order to develop a coordinated, integrated plan for treatment and long-term follow-up.

Research advance may lead to preservation of hearing in people with Usher syndrome type III

A research advance co-led by Case Western Reserve University School of Medicine's Kumar Alagramam, PhD, may stop the progression of hearing loss and lead to significant preservation of hearing in people with Usher syndrome type III, a form of hereditary hearing loss linked to defects in the sensory "hair" cells in the inner ear. USH3 is caused by a mutation in the clarin-1 gene.

Pharmacist in Walla Walla, WA

Barry Patzer, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2028 E Isaacs Ave, Walla Walla, WA 99362 Phone: 509-529-1917
Wayne Rickords, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 N Wilbur Ave, Walla Walla, WA 99362 Phone: 509-529-2008
Mr. Richard A Worthington, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Plaza Way, Walla Walla, WA 99362 Phone: 509-522-4672 Fax: 509-525-8985
Dr. Robert John Brawders, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-897-2055
Hiwot Bekele, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2222 E Isaacs Ave, Apt # E 101, Walla Walla, WA 99362 Phone: 919-600-0436
Mr. Barry Michael Mallard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1025 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-527-8000 Fax: 509-527-8183

Dr Jon Granbois, - Pharmacist in Walla Walla, WA